Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-849-94. Packaged in sachets

Labeling: Not Elsewhere Classified - Wrong NDC number

Recall #: D-0102-2025
Affected scope: 4404 packs
Initiated: November 14, 2024

Compiled from official public sources by the publisher. · Updated September 2026

Zydus Pharmaceuticals (USA) Inc recalled Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets,… - a low-severity action.

Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets,… was recalled by Zydus Pharmaceuticals (USA) Inc in December 11, 2024. Reason: Labeling: Not Elsewhere Classified - Wrong NDC number. Check the official notice for the remedy. Verify recall #D-0102-2025 with the FDA Drug before acting.

The recall

Zydus Pharmaceuticals (USA) Inc issued this low-severity FDA Drug recall-Labeling: Not Elsewhere Classified - Wrong NDC number.

Low
severity level: Class III
classification: December 11, 2024
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-0102-2025 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified low severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-849-94. Packaged in sachets

Reason for recall

Labeling: Not Elsewhere Classified - Wrong NDC number

Recall Profile

Structured summary of the FDA Drug recall record
Attribute	Value
Agency	U.S. Food and Drug Administration
Severity class	Low (Class III)
Status	Ongoing
Recall number	D-0102-2025
Date reported	December 11, 2024
Date initiated	November 14, 2024
Recalling firm	Zydus Pharmaceuticals (USA) Inc
Firm location	Pennington, NJ
Affected scope	4404 packs
Distribution	USA Nationwide.

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

Check the recall number (D-0102-2025) and product description against the item you own. Search the archive
Confirm the current status with FDA Drug before acting, recall details can be updated.
Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled? ▼

Why was this product recalled? ▼

Labeling: Not Elsewhere Classified - Wrong NDC number

Which agency issued this recall? ▼

This recall was issued by the FDA Drug on December 11, 2024. Severity: Low. Recall number: D-0102-2025.

Where was the recalled product distributed? ▼

Distribution: USA Nationwide..

Should I stop using a recalled medication or medical device? ▼

Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Similar severity · nearest report date

Same archive severity grade (Low), closest by report date among other firms and states.

Varithena (polidocanol injectable foam) A… 2024-12-18 Brand Name: Z-800 Infusion System Produc… 2024-12-04 Merlin@home Transmitter REF EX1100 The… 2024-12-04 Merlin@home with the MerlinOnDemand capab… 2024-12-04

Similar Drugs & Medications · nearest report date

Same product category, closest by report date among other firms and states (deduped against the severity set).

Levothyroxine Sodium Tablets, USP, 75 mcg… 2024-12-11 Venofer (iron sucrose) Injection, USP 100… 2024-12-11 Venofer (iron sucrose) Injection, USP 50 … 2024-12-11 Venofer (iron sucrose) Injection, USP 100… 2024-12-11

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: FDA Drug, reported December 11, 2024. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026